🇺🇸 FDA
Pipeline program

6QC-ICG, Placebo for 6QC-ICG

SPRAYDYE / CHDR2535

Phase 2 small_molecule active

Quick answer

6QC-ICG, Placebo for 6QC-ICG for Breast cancer is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Breast cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials